• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Register now
Search
Close this search box.

2022 Partners and Exhibitors

Diamond Partner

Santen

Platinum Partner

Alcon
DKSH_500x500

Supported by

MyCEB
MIM2_sponex_500x500
MTA

Exhibitors

Alcon
AOI_500x500
Bayer
DKSH_500x500
Ellex
Glaukos Aventisin 500x500
icare
Iridex
Kalson
JnJ Vision
Nova Eye
Novartis_500x500
Olleyes_500x500
Pharmaniaga
Santen
Swissme
Topcon
TRB
Zeiss

Floor plan

Screenshot of APGC Prospectus

INDUSTRY PARTNERSHIP

To discuss the congress and opportunities in the industry program, please contact:

Thomas Howden

Industry Liaison
Asia-Pacific Glaucoma Congress 2022
c/o MCI Australia

View prospectus

Keep me updated

Do you want to receive the latest APGC updates? Sign up to our mailing list!

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices please visit our website. MCI Group collects your personal data to submit information related to APGC. For more information, see our privacy statement.

About

Partners

Program

Congress Hosts

The Asia-Pacific Glaucoma Congress 2024 is made possible thanks to the following congress hosts: Philippine Academy of Ophthalmology and the Philippine Glaucoma Society.

Logo for the Philippine Academy of Ophthalmology
Logo for the Philippine Glaucoma Society

Follow us

#APGC2024
Facebook-square Twitter Linkedin-in Youtube Envelope
Join mailing list

Copyright 2021-2024 © APGC. All rights reserved.

Designed and built by MCI Australia

Santen

Santen

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. For more information, please visit https://www.santen.asia/

Alcon

Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

DKSH_500x500

DKSH

DKSH is the leading growth partner for pharmaceutical companies in Asia. Our experts provide a range of integrated Market Expansion Services across the entire value chain, ranging from registration through to marketing, promotion and distribution.
Our capillary network reaches more than 130,000 hospitals, clinics, pharmacies, doctors and drugstores in Asia. Products are transported, stored and distributed efficiently thanks to our unmatched capacities and expertise in the region. Our solid infrastructure and dedication to compliance and quality reduce business risks for our partners.
We are committed to delivering the results you need to be successful. That’s why we continuously invest in our sales and marketing organization, which is fully embedded in our operations. Our teams work with clear measurements, activity-driven KPIs and standardized brand planning processes across the region. They are supported by regional Sales and Marketing Excellence and Business Development teams, allowing us to duplicate success across markets.
Headquartered and publicly listed in Switzerland, our local experts provide services to pharmaceutical companies in 13 Asian markets.

AOI_500x500

Advanced Ophthalmic Innovations

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Bayer

Bayer Co. (Malaysia) Sdn Bhd

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. For more information, go to www.bayer.com.

Ellex

Ellex | Quantel Medical - Lumibird Medical

Since 1985 we’ve made it our mission to the help address the treatment needs and transform the sight of people across the Globe.

Since the exciting news of Lumibird Medical’s acquisition and merger of Ellex and Quantel Medical, our global focus continues to remain committed to providing innovative world-class technologies. Together Ellex and Quantel Medical have become the world leader in ophthalmology, with a presence in over 110 countries, either directly or via a distributor network – achieving ophthalmic outcomes once never thought possible – safely, effectively, accurately and consistently.

Our range of lasers and ultrasound platforms are designed to diagnose and treat the four main causes of blindness: cataract, glaucoma, diabetic retinopathy and macular degeneration. We also offer a range of devices to diagnose and treat dry eye.

Glaukos Aventisin 500x500

Glaukos Corporation / Aventisin

Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

We were the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure that revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.

In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for
glaucoma, corneal health, and retinal diseases.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is located in Aliso Viejo, California, and we have additional locations in 9 regions around the world.

icare

Icare

iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD).
Our devices cover automated fundus imaging systems, perimeters, and handheld rebound tonometers. iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
We believe that ophthalmic care must be accessible, effortless, and reliable, and our aim is to establish the next level of eye care.

Iridex

Iridex

At Iridex, we are redefining the glaucoma treatment paradigm with a versatile range of non-incisional, laser-based therapies: MicroPulse Laser Trabeculoplasty, MicroPulse Transscleral Laser Therapy, and Continuous-Wave Transscleral Cyclophotocoagulation. These therapies
provide physicians safe, effective, and versatile treatment options for a wide variety of glaucoma types and severities, to significantly reduce intraocular pressure and slow the progression of vision loss. More than 200,000 patients have been treated since 2015 with MicroPulse® TLT using the MicroPulse P3® Delivery Device. Visit iridex.com/webinars to learn how ophthalmologists and patients benefit from our non-incisional glaucoma procedures.

Kalson

Kalson Surgical

JnJ Vision

Johnson & Johnson Vision

Sponsor bio

Nova Eye

Nova Eye Medical

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Novartis_500x500

Novartis

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Olleyes_500x500

Olleyes

Pharmaniaga

Pharmaniaga

Pharmaniaga is proud to be the largest integrated pharmaceutical Group in Malaysia. In line with our commitment to excellence, we have established a strong reputation as a provider of quality products and services within the healthcare industry.

Our corporate philosophy is grounded in our motto, Passion for Patients. Above all, we are committed to delivering on our promise of high standards of excellence to our clients as part of our aim of creating a lasting legacy of doing business with a conscience.

The ambit of our business interests ranges from warehousing and distribution of pharmaceutical and medical products; generic pharmaceuticals manufacturing; marketing and sales; research and development; trading and installation of medical and hospital equipment. The Group has also successfully harnessed the synergies of our businesses to expand into the community pharmacy segment.

As an entity listed on the Main Board of Bursa Malaysia Securities Berhad with a strong domestic presence, we have been steadily growing our global presence through our expansion initiatives.

Swissme

Swissmed

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Topcon

Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and groundbreaking remote diagnostic technology.

A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

TRB

TRB Chemedica Malaysia

A subsidiary company of TRB CHEMEDICA INTERNATIONAL SA (Switzerland) established for almost 34 years in Malaysia, specialising in the use of hyaluronic acid in ophthalmology, rheumatology and orthopaedic for the management of ocular dryness, osteoarthritis and tendinopathy.

Zeiss

CARL ZEISS PTE.LTD.

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Abstract submission deadline extended

Important dates
Submission open: NOW!
Submission close: 1 Dec 2023 Monday 15 January 2024
Author notifications: 15 February 2024

Submit now